These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

150 related items for PubMed ID: 21762647

  • 1. Urinary interleukin-6 (IL-6) and transforming growth factor (TGF-β) levels in corticosteroidtreated patients with IgA nephropathy.
    Kalliakmani P, Nakopoulou L, Tsakas S, Gerolymos M, Papasotiriou M, Goumenos DS.
    Clin Nephrol; 2011 Aug; 76(2):144-50. PubMed ID: 21762647
    [Abstract] [Full Text] [Related]

  • 2. The effects of dual blockade of the renin-angiotensin system on urinary protein and transforming growth factor-beta excretion in 2 groups of patients with IgA and diabetic nephropathy.
    Song JH, Lee SW, Suh JH, Kim ES, Hong SB, Kim KA, Kim MJ.
    Clin Nephrol; 2003 Nov; 60(5):318-26. PubMed ID: 14640237
    [Abstract] [Full Text] [Related]

  • 3. Steroid therapy and urinary transforming growth factor-beta1 in IgA nephropathy.
    Haramaki R, Tamaki K, Fujisawa M, Ikedo H, Haramaki N, Okuda S.
    Am J Kidney Dis; 2001 Dec; 38(6):1191-8. PubMed ID: 11728950
    [Abstract] [Full Text] [Related]

  • 4. Effect of losartan and amlodipine on proteinuria and transforming growth factor-beta1 in patients with IgA nephropathy.
    Park HC, Xu ZG, Choi S, Goo YS, Kang SW, Choi KH, Ha SK, Lee HY, Han DS.
    Nephrol Dial Transplant; 2003 Jun; 18(6):1115-21. PubMed ID: 12748343
    [Abstract] [Full Text] [Related]

  • 5. Transforming growth factor-beta(1) in the kidney and urine of patients with glomerular disease and proteinuria.
    Goumenos DS, Tsakas S, El Nahas AM, Alexandri S, Oldroyd S, Kalliakmani P, Vlachojannis JG.
    Nephrol Dial Transplant; 2002 Dec; 17(12):2145-52. PubMed ID: 12454225
    [Abstract] [Full Text] [Related]

  • 6. Value of urinary levels of interleukin-6, epidermal growth factor, monocyte chemoattractant protein type1 and transforming growth factor β1 in predicting the extent of fibrosis lesions in kidney biopsies of patients with IgA nephropathy.
    Segarra-Medrano A, Carnicer-Caceres C, Valtierra-Carmeno N, Agraz-Pamplona I, Ramos-Terrades N, Jatem Escalante E, Ostos-Roldan E.
    Nefrologia; 2017 Dec; 37(5):531-538. PubMed ID: 28946966
    [Abstract] [Full Text] [Related]

  • 7. T helper (Th)-cytokines in the urine of patients with primary glomerulonephritis treated with immunosuppressive drugs: Can they predict outcome?
    Kalavrizioti D, Gerolymos M, Rodi M, Kalliakmani P, Provatopoulou S, Eleftheriadis T, Mouzaki A, Goumenos DS.
    Cytokine; 2015 Dec; 76(2):260-269. PubMed ID: 26307557
    [Abstract] [Full Text] [Related]

  • 8. Increased excretion of urinary transforming growth factor beta in patients with focal glomerular sclerosis.
    Kanai H, Mitsuhashi H, Ono K, Yano S, Naruse T.
    Nephron; 1994 Dec; 66(4):391-5. PubMed ID: 8015640
    [Abstract] [Full Text] [Related]

  • 9. Changes in urinary angiotensinogen posttreatment in pediatric IgA nephropathy patients.
    Urushihara M, Nagai T, Kinoshita Y, Nishiyama S, Suga K, Ozaki N, Jamba A, Kondo S, Kobori H, Kagami S.
    Pediatr Nephrol; 2015 Jun; 30(6):975-82. PubMed ID: 25523477
    [Abstract] [Full Text] [Related]

  • 10. Effect of corticosteroid therapy on the progression of IgA nephropathy with moderate proteinuria.
    Uzu T, Harada T, Ko M, Yamato M, Takahara K, Yamauchi A.
    Clin Exp Nephrol; 2003 Sep; 7(3):210-4. PubMed ID: 14586717
    [Abstract] [Full Text] [Related]

  • 11. Urinary transforming growth factor-beta in patients with glomerular diseases.
    Murakami K, Takemura T, Hino S, Yoshioka K.
    Pediatr Nephrol; 1997 Jun; 11(3):334-6. PubMed ID: 9203185
    [Abstract] [Full Text] [Related]

  • 12. Corticosteroid therapy in IgA nephropathy with minimal proteinuria and high renal pathological score: A single‑center cohort study.
    Tang Y, He H, Sun W, Hu P, Chen X, Xu X.
    Mol Med Rep; 2018 Oct; 18(4):4103-4112. PubMed ID: 30132546
    [Abstract] [Full Text] [Related]

  • 13. Noninvasive Urinary Monitoring of Progression in IgA Nephropathy.
    Yang JYC, Sarwal RD, Fervenza FC, Sarwal MM, Lafayette RA.
    Int J Mol Sci; 2019 Sep 10; 20(18):. PubMed ID: 31510053
    [Abstract] [Full Text] [Related]

  • 14. alpha-Tocopherol reduces proteinuria, oxidative stress, and expression of transforming growth factor beta 1 in IgA nephropathy in the rat.
    Chan W, Krieg RJ, Norkus EP, Chan JC.
    Mol Genet Metab; 1998 Mar 10; 63(3):224-9. PubMed ID: 9608545
    [Abstract] [Full Text] [Related]

  • 15. Urinary transforming growth factor-beta 1 in membranous glomerulonephritis.
    Honkanen E, Teppo AM, Törnroth T, Groop PH, Grönhagen-Riska C.
    Nephrol Dial Transplant; 1997 Dec 10; 12(12):2562-8. PubMed ID: 9430852
    [Abstract] [Full Text] [Related]

  • 16. Increased excretion of tumor necrosis factor alpha and interleukin 1 beta in urine from patients with IgA nephropathy and Schönlein-Henoch purpura.
    Wu TH, Wu SC, Huang TP, Yu CL, Tsai CY.
    Nephron; 1996 Dec 10; 74(1):79-88. PubMed ID: 8883024
    [Abstract] [Full Text] [Related]

  • 17. Urinary levels of interleukin-6 and disease activity in patients with IgA nephropathy.
    Tomino Y, Funabiki K, Ohmuro H, Shimizu M, Yokoyama K, Shirato I, Shirai T, Takahashi M, Koide H.
    Am J Nephrol; 1991 Dec 10; 11(6):459-64. PubMed ID: 1819212
    [Abstract] [Full Text] [Related]

  • 18. [Prognostic values of serum concentration and urinary excretion of interleukin-1 receptor antagonist and tumor necrosis factor receptors type I and II in patients with IGA nephropathy].
    Zwiech R, Kacprzyk F, Szuflet A, Nowicki M.
    Pol Arch Med Wewn; 2005 Apr 10; 113(4):326-33. PubMed ID: 16209246
    [Abstract] [Full Text] [Related]

  • 19. Clinicopathologic findings relevant to disappearance or relapse of proteinuria following corticosteroid treatment in IgA nephropathy patients with proteinuria of 0.5 to 2.0 g/day.
    Suzuki T, Yamamoto T, Ohura M, Fujigaki Y, Yonemura K, Kimura M, Hishida A.
    Clin Exp Nephrol; 2004 Sep 10; 8(3):243-9. PubMed ID: 15480902
    [Abstract] [Full Text] [Related]

  • 20. Comparison of combined leflunomide and low-dose corticosteroid therapy with full-dose corticosteroid monotherapy for progressive IgA nephropathy.
    Min L, Wang Q, Cao L, Zhou W, Yuan J, Zhang M, Che X, Mou S, Fang W, Gu L, Zhu M, Wang L, Yu Z, Qian J, Ni Z.
    Oncotarget; 2017 Jul 18; 8(29):48375-48384. PubMed ID: 28415636
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.